Conflicting therapeutic aspects during acute bronchiolitis in infants;Aspects therapeutiques conflictuels au cours des bronchiolites aigues du nourrisson

Archives de Pediatrie

Volumn 4, Issue SUPPL. 2, 1997, Pages

  Dutau, G ^a   Juchet, A ^a   Rittie J L ^a   Rance F ^a   Bremont F ^a   Nouilhan, P ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; RIBAVIRIN; SALBUTAMOL; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

BRONCHIOLITIS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; HUMAN; INFANT; PRACTICE GUIDELINE; ACUTE DISEASE; IMMUNOLOGY; REVIEW; VIRAL BRONCHIOLITIS;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; GLUCOCORTICOIDS; HUMANS; INFANT;

EID: 0030922482     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(97)86466-4     Document Type: Conference Paper

References (59)

1. e éd). Paris : PIL Edit, 1995:41-7
2. Bégué P, Grimprel E. Épidémiologie de la bronchiolite à VRS. Conséquences sur l'organisation des soins. Médecine et Enfance 1996;16:491-2
3. MacIntosh K. Bronchiolitis and asthma: possible common pathogenic pathways. J Allergy Clin Immunol 1976;57:594-604
4. MacConnochie KM. Bronchiolitis. Am J Dis Child 1983;1:11-3
5. Kellner G, Popow-Kraup T, Kundi M, Binder C, Wallner H, Kunz C. Contribution of rhinoviruses to respiratory tract infections in childhood. J Med Virol 1988;25:455-69
6. Rusconi F, Nizardo F, Cerveri I et al. Airway reactivity in parents of infants and young children with recurent wheeze: a case-control study. Arch Dis Child 1995;73:423-6
7. Pifferi M, Bertelloni G, Viegi G, Baldini M, Baldini G. Airway response to a bronchodilatator in healthy parents of infants with bronchiolitis. Chest 1994;105:706-9
8. Konig P, Godfrey S. Exercice-induced bronchial lability and atopic status of families of infants with wheezy bronchitis. Arch Dis Child 1973;48:942-6
9. Young S, O'Keeffe PT, Arnott J, Landau LI. Lung function, airway responsiveness and symptoms before and after bronchiolitis. Arch Dis Child 1995;72:16-24
10. Cohen R. Virus respiratoire syncytial: un virus et des surinfections bactériennes. Médecine et Enfance 1996;16:487-8
11. Cloutier MM, Wong D, Ogra PL. Respiratory syncytial virus alters electrophysiologic properties in cotton rat airway epithelium. Pediatr Pulmonol 1989;6:164-8
12. Dutau G. Les bronchiolites aiguës : un sujet presque inépuisable de controverses ! Médecine et Enfance 1996;16:501-14
13. Welliver RC, Wong DT, Sun M. The development of respiratory syncytial virus specific IgE and the release of histamine in nasopharyngeal secretion. N Engl J Med 1981;305:841-6
14. Welliver RC, Sun M, Rinaldo D, Ogra PL. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response. Pediatr Res 1985;19:420-6
15. Welliver RC, Sun M, Rinaldo D, Ogra PL. Predictive value of respiratory syncytial virus-specific IgE responses for for recurrent wheezing following bronchiolitis. J Pediatr 1986;109:776-80
16. Caswell SJ, Thomson AH, Ashmore SP, Beardsmore CS, Simpson H. Latent sensitisation to respiratory syncytial virus during acute bronchiolitis and lung function after recovery. Arch Dis Child 1990;65:946-52
17. Volovitz B, Faden H, Ogra PL. Release of leucotriene C4 in respiratory tract during infection. J Pediatr 1988;112:218-22
18. Volovitz B, Welliver RC, De Castro G, Krystofik D, Ogra PL. The release of leucotrienes in the respiratory tract during infection with respiratory syncytial: role in obstructive airway disease. Pediatr Res 1988;24:504-7
19. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992;120:28-32
20. Ingram JM, Razkes GE, Platts-Mills TAE, Heymann PW. Eosinophil cationic protein in serum and nasal washes from wheezy infants and children. J Pediatr 1995;127:558-64
21. Everard ML, Fox G, Walls AF et al. Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch Dis Child 1995;72:64-9
22. Dutau G. L'asthme du nourrisson. Une entité précise. Arch Fr Pédiatr 1993;50:551-2
23. e Congrès de l'association des pédiatres de langue française. Toulouse : Fournié Imp, 1981;2:165-7
24. De Blic J. Asthme du nourrisson. In : de Blic J, Scheinmann P, eds. Progrès en Pédiatrie 12. L'asthme... Paris : Doin, 1995:101-20
25. Milner AD, Murray M. Acute bronchiolitis in infancy: treatment and prognosis. Thorax 1989;44:1-5
26. Labbé A. La corticothérapie a-t-elle une place dans la prise en charge des bronchiolites aiguës du nourrisson ? Méd Mal Infect 1993 (spécial):883-5
27. Wang EEL, Law BJ, Boucher FD et al. Pédiatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with lower respiratory tract infection. J Pediatr 1996;129:390-5
28. Groupe francophone de réanimation pédiatrique. Prise en charge des bronchiolites aiguës du nourrisson. Propositions de la commission d'évaluation. Arch Pédiatr 1996;3:1191-2
29. Oski PA, Salitsky S, Barness LA. Steroid therapy in bronchiolitis:a double blind study. Am J Dis Child 1961;102:759-64
30. Tal A, Bavilski C, Yohai D, Beardman FE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71:13-8
31. Carlsen KH, LeeGaard J, Larsen S, Orstavik I. Nebulized beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 1988;63:1428-33
32. Noble V, Ruggins NR, Everard ML, Milner AD. Inhaled budesonide for chronic wheezing under 18 months of age. Arch Dis Child 1992;67:285-8
33. De Blic J, Delacourt C, Le Bourgeois M et al. Efficacy of nebulized budesonide in severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996;98:14-20
34. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med 1996;150:512-7
35. O'Callaghan C, Milner AD, Swarbrick A. Nebulised salbutamol does have a protective effect on airways in children under 1 year old. Arch Dis Child 1988;63:479-83
36. Dutau G, Brémont F, Juchet A, Rancé F, Nouilhan P. De la bronchiolite à l'asthme. Rev Fr Allergol 1994;34:28-32
37. Soto ME, Sly PD, Uren E, Taussig LM, Landau LI. Bronchodilator response during acute viral bronchiolitis in infancy. Pediatr Pulmonol 1985;1:85-90
38. Schuh S, Canny G, Reisman J et al. Nebulized albuterol in acute bronchiolitis. J Pediatr 1990;117:633-7
39. Schuh S, Johson D, Canny G et al. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics 1992;90:920-3
40. Klassen TP, Rowe PC, Sutcliffe T, Ropp LJ, McDowell IW, Li MM. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807-11
41. Tepper RS, Rosenberg D, Eigen H, Reister T. Bronchodilator responsiveness in infants with bronchiolitis. Pediatr Pulmonol 1994;17:81-5
42. Chevalier B, Aegerter P, Parat S, Bidat E, Renaud C, Lagardère B. Étude comparative des nébulisations de salbutamol contre placebo à la phase aiguë d'une bronchiolite chez 33 nourrissons de 1 à 6 mois. Arch Pédiatr 1995;2:11-7
43. Lowell W, Lister G, von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987;79:939-45
44. Reijonen T, Korppi M, Pitkäkangas S, Tenhola S, Remes K. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med 1995;149:686-92
45. Labbé A. Traitement de la bronchiolite aiguë. Place des bronchodilatateurs et des corticoïdes. Arch Pédiatr 1996;3:383-9
46. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulized salbutamol in wheezy infants. Lancet 1986;2:1424-5
47. Prendiville A, Rose A, Maxwell DI, Silverman M. Hypoxemia in wheezy infants after bronchodilator treatment. Arch Dis Child 1987;62:994-1000
48. Mallol J, Barrueto L, Girardi G, Toro O. Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device. Pediatr Pulmonol 1987;3:352-6
49. Henry RL, Milner AD, Stokes GM. Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch Dis Child 1983;58: 925-6
50. Stokes GM, Milner AD, Hodges IGC, Henry RL, Elphick MC. Nebulized therapy in acute severe bronchiolitis in infancy. Arch Dis Child 1983;58:279-83
51. es journées toulousaines de pneumo-allergologie pédiatrique, 16 octobre 1993. Toulouse : Corep Imp, 1993:16-20
52. Korppi M, Leinonen M, Koskela M, Makela PH, Launiala K. Bacterial coinfection in children hospitalized with syncytial virus infection. Pediatr Infect Dis J 1989;8:687-92
53. es Journées toulousaines de pneumo-allergologie pédiatrique, 28 avril 1995. CHU de Toulouse : Messages Imp, 1995:11-6
54. Dutau G, Dabernat H, Astruc et al. Surinfections bactériennes au cours des bronchiolites aiguës. Mythes ou réalités ? Médecine et Enfance 1996;16:403-6
55. Dutau G. Bronchiolite à VRS : identification des formes préoccupantes. Médecine et Enfance 1993;13:173-7
56. e réunion interdisciplinaire de chimiothérapie anti-infectieuse (RICAI), Paris, 1996
57. Asher MI, Douglas C, Airy M, Andrews D, Trenholme A. Effects of chest physical therapy on lung function in children recovering from acute severe asthma. Pediatr Pulmonol 1990;9:146-51
58. Barthe J, Binoche C, Brossard V. Pneumo-kinésithérapie. Paris : Doin, 1990:281-5
59. Demont B, Escourrou P, Camba CH, Grisan A, Odièvre M. Effets de la kinésithérapie respiratoire et des aspirations naso-pharyngées sur le reflux gastro-oesophagien chez l'enfant de 1 an avec et sans reflux pathologique. Arch Fr Pédiatr 1991;48:621-5